About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our group is dedicated to paediatric research. We are interested in rare respiratory and endocrinological diseases, and also in common paediatric problems such as normal growth, asthma, neonatal pathology and imaging diagnosis, as well as minority diseases. Our goal is to transfer the findings of clinical and genetic studies to the widespread clinical practice and the general population, with the long-term objective of obtaining better diagnoses, implementing better therapeutic practices and improving the health of children.
Our group is part of CIBERER (Biomedical Research Networking Centre on Rare Diseases) (CIBERER U712) and European Reference Networks (ERN) for rare diseases ERN LUNG and Endo-ERN.
PMID: 33661460 Journal: ENDOCRINE Year: 2021 Reference: Endocrine. 2021 Mar;71(3):586-594. doi: 10.1007/s12020-021-02649-6. Epub 2021 Mar 4. Impact factor: 3.633 Publication type: Review in international publication Authors: Lajic, Svetlana, Nowotny, Hanna, Ahmed, S Faisal, Bensing, Sophie, Beun, Johan G, Brosamle, Manuela, Chifu, Irina, Claahsen van der Grinten, Hedi, Clemente, Maria, Falhammar, Henrik et al. DOI: 10.1007/s12020-021-02649-6
PMID: 33637432 Journal: Journal of Cystic Fibrosis Year: 2021 Reference: J Cyst Fibros. 2021 Sep;20(5):820-823. doi: 10.1016/j.jcf.2021.02.006. Epub 2021 Feb 23. Impact factor: 5.482 Publication type: Letter whit IF Authors: Munck, Anne, Southern, Kevin W, Castellani, Carlo, de Winter-de Groot, Karin M, Gartner, Silvia, Kashirskaya, Nataliya, Linnane, Barry, Mayell, Sarah J, Proesmans, Marijke, Sands, Dorota et al. DOI: 10.1016/j.jcf.2021.02.006
PMID: 33619748 Journal: PEDIATRIC ALLERGY AND IMMUNOLOGY Year: 2021 Reference: Pediatr Allergy Immunol. 2021 Jul;32(5):980-991. doi: 10.1111/pai.13484. Epub 2021 Mar 20. Impact factor: 6.377 Publication type: Paper in international publication Authors: Valdesoiro Navarrete, Laura, Ballester Asensio, Esther, Sanz Santiago, Veronica, Romero Garcia, Raquel, Gimeno Diaz de Atauri, Alvaro, Valenzuela Soria, Alfredo, Sanchez Mateos, Mercedes, Batlles Garrido, Jose, Andres Martin, Anselmo, Campos Alonso, Elena et al. DOI: 10.1111/pai.13484
PMID: 33598926 Journal: CLINICAL GENETICS Year: 2021 Reference: Clin Genet. 2021 Jun;99(6):789-801. doi: 10.1111/cge.13943. Epub 2021 Feb 28. Impact factor: 4.438 Publication type: Paper in international publication Authors: Rapp Christina, K, Li, Yang, Smith Desiree, E C, Mendes Marisa, I, Delhommel, Florent, Sattler, Michael, Emiralioglu, Nagehan, Taskiran Ekim, Z, Orhan, Diclehan, Kiper, Nural et al. DOI: 10.1111/cge.13943
PMID: 29285648 Journal: EUROPEAN JOURNAL OF PEDIATRICS Year: 2018 Reference: Eur J Pediatr. 2018 Feb;177(2):181-192. doi: 10.1007/s00431-017-3044-3. Epub 2017 Dec 29. Impact factor: 2.242 Publication type: Paper in international publication Authors: Garcia-Corbeira, Pilar, Talarico, Carla A, Castillo Corullon, Silvia, Barrio Gomez de Aguero, Maribel, Sanchez Solis, Manuel, Moreno Galdo, Antonio, Reyes, Janet, Van Dyke, Melissa K, Torrent Vernetta, Alba, Escribano Montaner, Amparo et al. DOI: 10.1007/s00431-017-3044-3
PMID: 28935165 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2018 Reference: Arch Bronconeumol. 2018 Jan;54(1):24-30. doi: 10.1016/j.arbres.2017.07.019. Epub 2017 Sep 19. Impact factor: 2.633 Publication type: Paper in national publication Authors: de Mir Messa, Ines, Martin de Vicente, Carlos, Gartner, Silvia, Iglesias Serrano, Ignacio, Carrascosa Lezcano, Antonio, Moreno Galdo, Antonio, Torrent Vernetta, Alba, Rovira Amigo, Sandra et al. DOI: 10.1016/j.arbres.2017.07.019
PMID: 28124681 Journal: Revista Espanola de Salud Publica Year: 2017 Reference: Rev Esp Salud Publica. 2017 Jan 25;91. pii: e201701009. Impact factor: 0.69 Publication type: Paper in national publication Authors: Manzano Varo, Cristina, Garcia-Algar, Oscar, Mur Sierra, Antonio, Ferrer Costa, Roser, Carrascosa Lezcano, Antonio, Yeste Fernandez, Diego, Ortigosa Gomez, Sandra et al. DOI:
PMID: 28161392 Journal: ANALES DE PEDIATRIA Year: 2017 Reference: An Pediatr (Barc). 2017 Aug;87(2):116.e1-116.e10. doi: 10.1016/j.anpedi.2016.12.002. Epub 2017 Feb 1. Impact factor: 1.14 Publication type: Paper in national publication Authors: Rodriguez, Amparo, Ezquieta, Begona, Labarta, Jose Igancio, Clemente, Maria, Espino, Rafael, Rodriguez, Amaia, Escribano, Aranzazu et al. DOI: 10.1016/j.anpedi.2016.12.002
The study, in which Vall d'Hebron participates, helps to understand the variability among patients with retinitis pigmentosa.
Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.
The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.
